Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Perry T. Yin"'
Autor:
Hyeon‐Yeol Cho, Myungsik Yoo, Thanapat Pongkulapa, Hudifah Rabie, Alysson R. Muotri, Perry T. Yin, Jeong‐Woo Choi, Ki‐Bum Lee
Publikováno v:
Advanced Science, Vol 11, Iss 24, Pp n/a-n/a (2024)
Abstract The CRISPR‐Cas9 technology has the potential to revolutionize the treatment of various diseases, including Rett syndrome, by enabling the correction of genes or mutations in human patient cells. However, several challenges need to be addre
Externí odkaz:
https://doaj.org/article/7124b7eb05c34190b1e27d9c94807b25
Autor:
Marie Louise Edwards, Perry T. Yin, Michael Kuehn, Keith Bratti, Noam Kirson, Anupam B. Jena, Scott Howell
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
The use of drug utilization management techniques such as formulary exclusions, prior authorizations, and step edits has risen sharply during the last decade, contributing to the growing burden on physicians and patients. Limited quantitative data ex
Externí odkaz:
https://doaj.org/article/9e0813eb22a048a3835b6b20532d2384
Publikováno v:
Health Affairs. 40:1206-1214
The continuing launch of innovative but high-price drugs has intensified efforts by payers to manage use and spending and by pharmaceutical manufacturers to support patient access and sales. Payers are restricting drug formularies, requiring more str
Publikováno v:
Health affairs (Project Hope). 40(11)
Publikováno v:
Health affairs (Project Hope). 40(8)
The continuing launch of innovative but high-price drugs has intensified efforts by payers to manage use and spending and by pharmaceutical manufacturers to support patient access and sales. Payers are restricting drug formularies, requiring more str
Autor:
Bhavin, Patel, Patrick, Mayne, Tanay, Patri, Joe, Vandigo, Perry T, Yin, Keith, Bratti, Scott, Howell
Publikováno v:
JAMA Health Forum. 3:e221167
This cohort study uses a longitudinal access and adjudication data set to evaluate prescription out-of-pocket costs and filling behaviors of commercially insured individuals with chronic obstructive pulmonary disease (COPD).
Publikováno v:
Biomaterials. 81:46-57
Stem cell-based gene therapies, wherein stem cells are genetically engineered to express therapeutic molecules, have shown tremendous potential for cancer applications owing to their innate ability to home to tumors. However, traditional stem cell-ba
Autor:
Jong Min Lee, Jong-Hoon Kim, Jiyou Han, Letao Yang, Perry T. Yin, Bong Geun Chung, Ki-Bum Lee, Tae-Hyung Kim, Hyeon-Yeol Cho, Sy-Tsong Dean Chueng, Jeffrey Luo, Yannan Hou, Jeong-Woo Choi
Publikováno v:
Adv Funct Mater
Nanoparticle-based nucleic acid conjugates (NP-NACs) hold great promise for theragnostic (diagnostic and therapeutic) applications. However, several limitations have hindered the realization of their full potential in the clinical treatment of cancer
Autor:
Jeong-Woo Choi, Perry T. Yin, Hyeon-Yeol Cho, Jong-Hoon Kim, Jiyou Han, Hudifah Rabie, Thanapat Pongkulapa, Nicholas Pasquale, Ki-Bum Lee
Publikováno v:
ACS applied materialsinterfaces. 10(32)
In this study, we report the use of a multifunctional magnetic core–shell nanoparticle (MCNP), composed of a highly magnetic zinc-doped iron oxide (ZnFe2O4) core nanoparticle and a biocompatible mesoporous silica (mSi) shell, for the simultaneous d
Publikováno v:
Clinical Pharmacology and Therapeutics